Drug Shortage Report for BIO-PRAVASTATIN
| Report ID | 86094 |
| Drug Identification Number | 02446278 |
| Brand name | BIO-PRAVASTATIN |
| Common or Proper name | PRAVASTATIN |
| Company Name | BIOMED PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | PRAVASTATIN SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-11 |
| Estimated end date | |
| Actual end date | 2020-09-30 |
| Shortage status | Resolved |
| Updated date | 2020-10-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-06-11 | English | Compare |
| v2 | 2019-06-11 | French | Compare |
| v3 | 2019-06-12 | English | Compare |
| v4 | 2019-08-21 | English | Compare |
| v5 | 2019-08-21 | French | Compare |
| v6 | 2020-09-30 | English | Compare |
| v7 | 2020-09-30 | French | Compare |
| v8 | 2020-10-01 | English | Compare |
Showing 1 to 8 of 8